This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
Our approach, grounded in Good Laboratory Practice (GLP) and honed through thousands of studies, ensures that even the most subtle toxicological indicators are reliably detected. Sompura, Method Development Team Lead at Sannova Analytical, brings over 18 years of experience in the Bioanalytical Laboratory Department.
Mass spectrometry imaging (MSI) enables the direct detection and quantitation of active pharmaceutical ingredients (APIs) and metabolites within tissue sections, making it widely regarded as a promising technique in the field of pharmacology and toxicology.
As the pharmaceutical industry continues to evolve, drug developers encounter new challenges and opportunities in their pursuit of innovation. Patient recruitment and clinical laboratory and diagnostic services are the top drug development activities likely to be outsourced, similar to previous reports.
In the rapidly evolving landscape of life sciences, the communication gap between laboratory scientists and data scientists remains a significant challenge. I began developing my own scripts to streamline processes, which led me into scientific informatics, where I worked with pharmaceutical companies on cheminformatics.
For biotechnology and pharmaceutical companies, automation can decrease their drug-to-market development time and remain financially competitive in an evolving market. My experience as an optimization scientist has shown how automation can be a valuable tool to support drug development for sponsors of all sizes.
In this context, the USP’s mAb reference standards offer pharmaceutical manufacturers a critical benchmark. With Bio-Techne’s global distribution network and integrated analytical platforms like the MauriceFlex™, more laboratories can now seamlessly adopt these standards into their workflows. “We
Dr. Marjorie Green, Senior Vice President and Head of Oncology Global Clinical Development at Merck Research Laboratories, emphasized the significance of this new trial within the broader scope of the ADC’s development.
Guide for the Care and Use of Laboratory Animals. NIH Office of Laboratory Animal Welfare – Training Guidelines. Alternatives to Laboratory Animals , 50(3). iPSC-cardiomyocytes in the preclinical prediction of candidate pharmaceutical toxicity. Federal ruling on USDA primate welfare petition, 2023. Bailey J, et al.
Alnylam Elevates Dr. Pushkal Garg to Lead Unified Research and Development Organization, Signaling Strategic Expansion into Next Phase of RNAi Therapeutics Innovation Alnylam Pharmaceuticals , a global leader in RNA interference (RNAi) therapeutics, has announced the promotion of Pushkal Garg, M.D.,
The two companies have signed a Memorandum of Understanding (MoU) to provide comprehensive support and resources to Japanese drug-discovery startups, helping them bring their innovations from laboratory benches toward eventual global delivery of new medicines. Source link
In recent years, advanced manufacturing has gained traction in the pharmaceutical industry, transforming how drugs are developed, produced, and delivered. 3D printing (additive manufacturing) : In the pharmaceutical sector, 3D printing allows for personalized medicine by creating precise dosages and unique drug delivery systems.
For three decades now, Altasciences has taken pride in evolving their solutions to meet the needs of pharmaceutical and biotechnology companies of all sizes, including the expansion of their labs in Seattle, WA, Columbia, MO, and Laval, Quebec. View the fascinating video series here.
Bayer and Tsinghua University Deepen Strategic Alliance to Advance Pharmaceutical Innovation in China Bayer and Tsinghua University (THU), two powerhouses in global pharmaceutical innovation and academic research, have announced a renewed commitment to their long-standing partnership.
FDA Grants Accelerated Approval to Regeneron’s Lynozyfic™ (linvoseltamab-gcpt) for Relapsed or Refractory Multiple Myeloma Regeneron Pharmaceuticals has secured a critical milestone in oncology drug development with the U.S.
ALTASCIENCES’ FLOW CYTOMETRY SERVICES Our clinical facilities at Altasciences are integrated with state-of-the-art flow cytometry laboratories. We are all pushing the boundaries in terms of technology while acknowledging the importance of guidelines to ensure scientific reliability.
Case Study: How to Ensure Safety While Manufacturing Highly Potent APIs aasimakopoulos Mon, 11/04/2024 - 17:37 Highly potent active pharmaceutical ingredients (API) require careful attention to safety and handling during formulation and manufacturing.
The campus design is anchored by a Z-shaped laboratory and R&D office complex that forms a prominent urban frontage—serving as both a gateway to innovation and a symbolic link between science and the broader community.
In 2016, he was appointed Junior Group Leader with the Swiss National Centre for Competence in Research (NCCR) in RNA & Disease, where he established the laboratory for Genomics Of LncRNAs in Disease (GOLD Lab).
Working at the famed Pasteur Institute, the duo began by figuring out how best to culture mycobacteria — a seemingly simple, but essential first step, given how no one at the time had yet come up with an effective way of growing these bacteria in the laboratory. Many more could emerge as machine learning tools improve.
Aaron Haubner, PhD, MBA is the Senior Manager, North America Medical Affairs and Market Access at Terumo Blood and Cell Technologies Aaron earned his doctorate in pharmaceutical sciences and his MBA in finance. Use of Disease-Modifying Treatments in Patients with Sickle Cell Disease. JAMA Network Open.
The pharmaceutical landscape is evolving rapidly, with small and medium-sized biotech companies increasingly taking center stage in innovation. Managing Quality and Compliance Quality and regulatory compliance are non-negotiable in pharmaceutical manufacturing. How can you ensure your CDMO is up to scratch?
This skillset, shared by Oncley and several others who later become key fixtures in Cohn’s laboratory, proved invaluable to wartime efforts when it became clear that many protein purification experiments would require extensive modification of instruments to work at scale. Curious researchers from external laboratories often attended.
Josh’s work at the Marine Biological Laboratory unlocked the potential of utilizing an endogenous protein to make a single alphabet change on RNA (RNA editing), a process that was precise, reversible and had druglike characteristics. We intended to learn from nature (genetics) and use pharmaceuticals properties to drive patient benefit.
To address the issues of time and cost, pharmaceutical companies rely on central laboratories (CLs) for consistency, organization, and efficiency during the clinical trial phase, which is essential for drug approval.
Medical researchers and practitioners see in their own patients how these ailments interconnect and overlap, as do the pharmaceutical and biotech companies working to develop GLP-1 therapeutics. In todays active development landscape, GLP-1 studies face strong competition and potentially low retention rates.
Published June 26, 2025 Ned Pagliarulo Lead Editor post share post print email license An Incyte researcher works in a laboratory. On June 26, 2025, the company announced the replacement of longtime CEO Hervé Hoppenot with Bill Meury.
My goal is not only to tell the story of a pharmaceutical staple but to share what my decades-long work in evidence synthesis in epidemiology has taught me about researching scientific history. Eichengrün’s laboratory at Bayer. 11 Ernst Arthur Eichengrün, photographed in 1896.
Navigating the Complex World of CDMO Contracts: What to Look Out For As a pharmaceutical professional, you're likely no stranger to the importance of finding the right Contract Development and Manufacturing Organization (CDMO) partner. Regulatory Compliance Regulatory compliance is a top priority in the pharmaceutical industry.
Regeneron Unveils Groundbreaking $200 Million Donation Matching Program to Expand Patient Access to Vision-Saving Treatments Regeneron Pharmaceuticals , a leader in biotechnology and a longtime advocate for equitable healthcare access, has announced a bold new philanthropic initiative designed to support patients facing debilitating eye diseases.
Falling out of fashion with the rise of the modern pharmaceutical industry, it’s ready for a comeback driven not by mania, but rather by a mechanistic understanding of the molecules and bioactive compounds responsible for its efficacy. What are the bottlenecks of tree engineering, and what would overcoming them solve?
Good laboratory practice (GLP) ensures the safety, quality, and organization of pharmaceutical research. This article highlights the most common good laboratory practice examples. During the research process, each member of a team must perform their duties to the set quality assurance standards.
A cornerstone of digital transformation, these solutions are accelerating the transition to Pharma 4.0 – a future vision of the pharmaceutical industry characterized by smart production workflows, flexible value chains and real-time process optimization. Advances in laboratory informatics solutions are easing the path to Pharma 4.0.
There has been an unprecedented expansion of different types of pharmaceutical therapies, as well as a change in the overall approach to health care. 1 With this growth comes increased demands for laboratory services at all steps across the development process. Stay ahead of the curve with a great GMP/CMC contract laboratory partner.
Altasciences Completes Expansion of New State-Of-The-Art Laboratory in Columbia, Missouri pmjackson Tue, 10/31/2023 - 16:08 Laval, Québec, October 31, 2023 – Altasciences is pleased to announce the completion of its laboratory facilities in Columbia, MO. This is Altasciences’ third purpose-built laboratory.
Likewise, to achieve comprehensive visibility of laboratory, manufacturing or supply chain processes, gathering real-time data on critical quality attributes and environmental conditions is key. With laboratory data used to make critical decisions downstream, it is essential that information is accurate and complete.
Exploring how digital transformation will revolutionize process optimization and decision-making within the pharmaceutical industry Networked digital technologies and advanced automation are transforming pharmaceutical manufacturing , enabling efficiencies through real-time process optimization and faster decision-making. value chain.
HYDERABAD, India–( BUSINESS WIRE )– Dr. Reddy’s Laboratories Ltd. About Dr. Reddy’s : Dr. Reddy’s Laboratories Ltd. Reddy’s”) is an integrated pharmaceutical company, committed to providing affordable and innovative medicines for healthier lives. 28, 2020 10:09 UTC. KMP* – Key Managerial Personnel.
He previously helped build pharmaceutical manufacturing sites across the world, including a plant in China in the 1980s. HARRIMAN, TN, October 23, 2020 /24-7PressRelease/ — Richard M. He previously helped build pharmaceutical manufacturing sites across the world, including a plant in China in the 1980s.
Receiving Fast Track designation is an important acknowledgment of the results of our COVID-19 laboratory research,” commented Leo Ehrlich, Chief Executive Officer at Innovation Pharmaceuticals. Brilacidin antiviral research to date has been limited to laboratory-based experiments.
Source link.
In the pharmaceutical industry, the successful transition of a drug substance from the controlled environment of the laboratory to large-scale production at a manufacturing plant is critical.
Industry guidelines require biopharmaceutical and biotechnology companies to test their pharmaceutical packaging systems, as the systems often experience prolonged and intimate contact with drug products, drug substances and intermediates. In clinical research, the role of drug packaging systems cannot be overlooked. > requirements.
Digital transformation is revolutionizing pharmaceutical research and manufacturing. Now, pharmaceutical industry stakeholders, including technology vendors, are taking the lead to facilitate change. The vast majority of pharmaceutical workflows utilize instruments and digital technologies from multiple vendors.
16, 2020 /PRNewswire/ — Lipidor AB (Nasdaq First North: LIPI) announced today that the Company has signed a new cooperation agreement with Aurena Laboratories AB. Under the agreement, Aurena Laboratories will establish a production unit to meet the regulatory requirements for the manufacture of Lipidor’s pharmaceutical products.
1 As we have mentioned before in our whitepaper, digital revolution in the pharmaceutical industry , in order to stay competitive in this new business climate holistic digital transformation must occur. Platform technologies are beginning to come to market to provide a connected laboratory.
We organize all of the trending information in your field so you don't have to. Join 15,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
Let's personalize your content